June 5, 2019Breast Cancer Research and Treatment171 citationsOpen Access
HER2+ breast cancer treatment and cardiotoxicity: monitoring and management
Structured PICO
P
Population
Patients with HER2+ breast cancer
I
Intervention
Cardiotoxicity management (including new imaging modalities, biomarkers, interventional therapies)
This review highlights emerging techniques, including imaging and biomarkers, for managing cardiotoxicity in patients undergoing HER2+ breast cancer treatment.
Abstract
The future of cardiotoxicity management in patients with HER2+ breast cancer is discussed, with a focus on novel techniques to improve cardiac outcomes, including new imaging modalities, biomarkers, interventional therapies, and ongoing trials.